You are here

Article Text

Article menu
Download PDFPDF
PostScript
Featured correspondence
The Author's reply
  1. N Curzen
  1. Correspondence to Nick Curzen, Southampton University Hospital NHS Trust, Wessex Cardiothoracic Centre, Southampton, SO16 6YD, UK; nick.curzen{at}suht.swest.nhs.uk

https://doi.org/10.1136/hrt.2010.197285

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The Author's reply: I am grateful to Dr Lozano for his supportive comments.1 I entirely agree that it is appropriate to emphasize the benefits of successful revascularisation in patients with stable angina even when prognostic improvement may be less clear cut. Specifically, an improvement in symptoms, better quality of life and reduced requirement for anti-anginal medication are clearly of great clinical value and should not be underestimated, …

    View Full Text

    Footnotes

    • Linked articles 197277

    • Competing interests Dr Curzen is the recipient of an unrestricted research grant from St Jude Medical as Chief Investigator for the RIPCORD study.

    • Provenance and peer review Commissioned; not externally peer reviewed.

    Linked Articles